Xarelto® Manufacturers Accused of Misleading Medical Journal
March 9th, 2016|
Pharmaceutical companies makes billions each year from the medications they manufacture. When these drugs operate as intended, the results can be lifesaving. However, when unintended side effects cause more harm than good, the manufacturer has a responsibility to warn the public and pull the drug from the shelves. Unfortunately, some manufacturers choose to do the opposite, concealing the risks in the interests of profits.
Recently, the The New York Times reported that Johnson & Johnson and Bayer, manufacturers of the blood-thinning medication Xarelto®, potentially mislead the editors of a prestigious medical journal by failing to provide important data that may have impacted the results of their study. Some believe the manufacturers concealed this information to ensure doctors continue to prescribe the drug even though doing so may put their patients at risk.
Xarelto has been linked to an increased risk of severe bleeding, stroke, and blood clots in certain patients, which can lead to serious injury or death. If you or someone you love suffered complications after taking Xarelto, call our drug injury lawyers today. Ferrer, Poirot & Wansbrough has recovered hundreds of millions of dollars for our clients, and we’re ready to put that experience to work for you. Call today for a free consultation—24 hours a day, seven days a week.
Xarelto® is a registered trademark of Bayer AG and Johnson & Johnson and is used here only for the purpose of identifying the product in question.
This law firm is not associated with, sponsored by, or affiliated with Bayer AG, Johnson & Johnson, or The New York Times.